WallStreetZenWallStreetZen

NASDAQ: ASND
Ascendis Pharma A Stock Ownership - Who owns Ascendis Pharma A?

Insider buying vs selling

Have Ascendis Pharma A insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASND insiders and whales buy or sell their stock.

ASND Shareholders

What type of owners hold Ascendis Pharma A stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ra Capital Management LP17.51%10,107,400$1.37BInstitution
Artisan Partners Limited Partnership9.96%5,749,227$781.32MInstitution
Fmr LLC8.86%5,114,369$695.04MInstitution
Westfield Capital Management Co LP6.98%4,030,634$547.76MInstitution
Janus Henderson Group PLC6.92%3,994,785$542.89MInstitution
T Rowe Price Investment Management Inc6.91%3,989,830$542.22MInstitution
Avoro Capital Advisors LLC6.51%3,755,555$510.38MInstitution
Wellington Management Group LLP5.63%3,248,293$441.44MInstitution
Capital International Investors3.78%2,181,268$296.43MInstitution
Massachusetts Financial Services Co2.63%1,519,219$206.46MInstitution

1 of 3

ASND vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
ASND100.00%0.00%
CERE26.94%73.06%Net BuyingNet Selling
VKTX69.23%9.05%Net SellingNet Selling
LEGN23.61%0.00%
EXEL85.28%4.07%Net SellingNet Buying

Ascendis Pharma A Stock Ownership FAQ

Who owns Ascendis Pharma A?

Ascendis Pharma A (NASDAQ: ASND) is owned by 104.34% institutional shareholders, 0.00% Ascendis Pharma A insiders, and 0.00% retail investors. Ra Capital Management LP is the largest individual Ascendis Pharma A shareholder, owning 10.11M shares representing 17.51% of the company. Ra Capital Management LP's Ascendis Pharma A shares are currently valued at $1.37B.

If you're new to stock investing, here's how to buy Ascendis Pharma A stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.